Component E-C Implants with Tylan 29 mg (Tylosin Tartrate IMPLANT) 29 MG

Component E-C Implants with Tylan 29 mg are subcutaneous implants containing tylosin tartrate, used for therapeutic purposes in veterinary medicine. These implants are designed for easy administration and controlled release.

Strength

29 MG

Pack Size

100

Manufacturer / TM Owner

ELANCO CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Component E-C Implants with Tylan 29 mg are primarily used for therapeutic purposes in animals. Tylosin tartrate, the active ingredient, is often utilized for managing certain bacterial infections. These implants provide a convenient method of administration, ensuring a steady release of the medication over time. Veterinarians may recommend these implants for conditions where prolonged treatment is necessary.

Side Effects

The effects of Component E-C Implants with Tylan 29 mg are typically observed over a period of time due to their controlled release mechanism. Users may notice improvements in the animal's condition as the medication is gradually absorbed. Common effects include reduced symptoms associated with bacterial infections, promoting overall health and well-being.

Precautions & Warnings

When handling Component E-C Implants with Tylan 29 mg, it is important to follow proper subcutaneous administration techniques. Ensure the implants are stored as per the manufacturer's guidelines to maintain their efficacy. Always consult with a veterinarian before use to determine the appropriate treatment plan for the animal.

Avoid Interactions

Component E-C Implants with Tylan 29 mg may interact with other medications, particularly those with similar mechanisms of action. It is advisable to inform your veterinarian about any other treatments the animal is receiving to avoid potential interactions. Additionally, certain substances may affect the absorption or effectiveness of tylosin tartrate.

Frequently Asked Questions

Component E-C Implants with Tylan 29 mg are used for managing certain bacterial infections in animals through the controlled release of tylosin tartrate.

These implants are designed for subcutaneous administration, providing a steady release of the medication over time.

Users may observe improvements in the animal's condition as the medication is gradually absorbed, reducing symptoms associated with bacterial infections.

Proper administration techniques and storage conditions are important. Always consult with a veterinarian before use.

Yes, they may interact with other medications. Inform your veterinarian about any other treatments the animal is receiving.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.